Find key information for shareholders in 4D pharma plc
Registered office
4D pharma plc
Third Floor
9 Bond Court
Leeds LS1 2JZ
Share information
There are 64,858,150 ordinary shares in issue. There are no ordinary shares held in treasury. Therefore, the total number of voting rights in the Company is 64,858,150.
Please view the table below for the interests of shareholders of 3% or more which have been notified to the Company. Other directors who are also shareholders include Thomas Engelen (0.8%).
Insofar as the Company is aware, the percentage of the Company’s issued ordinary shares that is not in public hands is 72.1%.
There are no restrictions as to the transfer of ordinary shares.
Major shareholders
| Ordinary shares held | % | |
| Woodford Investment Management LLP | 17,514,561 | 27.0% |
| Invesco Asset Management Limited | 9,163,617 | 14.1% |
| David Robert Norwood | 7,000,000 | 10.8% |
| Duncan Joseph Peyton | 6,250,286 | 9.6% |
| Alexander James Stevenson | 6,250,286 | 9.6% |
| Lansdowne Partners | 3,000,000 | 4.6% |
This information was last updated on 10 March 2017.
Meetings and voting
Advisers and registrars
Zeus Capital Limited
82 King Street
Manchester M2 4WQ
and
41 Conduit Street
London W1S 2YQ
Investec Bank plc
2 Gresham
Street
London
EC2V 7QP
RSM UK Audit LLP
3 Hardman Street
Manchester M3 3HF
Capita Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU
